Genmab — Maj 2020
-
Enig Bulder.
-
Får Genmab også 10% på Teclistamab og Talquetamab? Der er vel kun dobbel digit hvis begge ben i duobodien er udviklet af Genmab (som Amivantamab).
-
yes but I beleive
royalties are higher if both legs in the duo are developed by Genmab... -
ofcourse
-
yes I agree
-
-
@11.17 i see no reaseon for him not to answer, for amivantamab it is explicitly stated on their website https://www.genmab.com/product-pipeline/products-in-development/amivantamab
-
Medicinrådet siger nej til Darzalex udfordrer fra BMS https://medwatch.dk/Medicinal___Biotek/article12152125.ece
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
